miRNA-432 and SLC38A1 as Predictors of Hepatocellular Carcinoma Complicated with Alcoholic Steatohepatitis.
Chao CaiJing LinJi LiXiao-Dong WangLan-Man XuDa-Zhi ChenYong-Ping ChenPublished in: Oxidative medicine and cellular longevity (2022)
Alcoholic steatohepatitis (ASH) is asymptomatic in the early stages and is typically advanced at the time of diagnosis. With the global rise in alcohol abuse, ASH is currently among the most detrimental diseases around the world. Hepatocellular carcinoma (HCC) is one of the final outcomes of numerous liver diseases. However, at present, HCC screening is mostly focused on liver cancer development. Moreover, there is no effective biomarker to predict the prognosis and recurrence of liver cancer. Meanwhile, there are limited studies on the prognosis and recurrence of HCC patients complicated with ASH. In this study, using bioinformatic analysis as well as cellular and animal models, we screened the differentially expressed (DE) miRNA-432 and SLC38A1 gene in ASH. Based on our analysis, miRNA-432 targeted SLC38A1, and the levels of miRNA-432 and SLC38A1 could accurately predict the overall survival (OS) and relapse free survival (RFS) in patients with liver cancer. Hence, these two genetic elements have the potential to synergistically predict the prognosis and recurrence of HCC complicated with ASH.
Keyphrases
- free survival
- municipal solid waste
- sewage sludge
- end stage renal disease
- ejection fraction
- genome wide
- chronic kidney disease
- copy number
- prognostic factors
- type diabetes
- cancer therapy
- adipose tissue
- peritoneal dialysis
- dna methylation
- anaerobic digestion
- patient reported outcomes
- skeletal muscle
- transcription factor
- drug delivery